[ALA Client News] Clean Cells acquires Anaquant to expand analytical capabilities in biomanufacturing quality control ala.associates/corporate/cl... #biomanufacturing #qualitycontrol

[Client Case Study] In 2026, ALA collaborated with @exciva-gmbh.bsky.social on three news releases covering a Series B fundraising, an executive appointment and a clinical trial launch The campaign generated 150+ media coverages, reaching an audience of 63M+ readers.

[ALA Client News] Caixa Capital Risc rebrands as Criteria Capital Risc and targets €300M investment volume by 2030 ala.associates/corporate/ca... #funding #biotech #tech

Celebrating our clients' media successes 🌟 We’re proud to share some of our clients’ highlights in the media published in June: 1️⃣ Grapheal in Aquatech. Vincent Bouchiat shared his expert insights on European regulations on PFAS and advancements in portable detection technologies.

[ALA Client News] Genoskin Doubles US Foothold to Launch Local Primary Human Mast Cell Production for North American Customers ala.associates/corporate/ge... #mastcells #drugdiscovery

🎙️[ALA Client in the News] Tune into the latest episode of Med Tech Gurus, where Philippe Bencteux, CEO of Robocath joins Thomas Hickey to discuss how robotic platforms are redefining precision, safety, and access in cardiovascular procedures. www.youtube.com/watch?v=L3KA... #cardiovascular #robotics

Robotics in the Cath Lab | Philippe Bencteux, MD | The Future of Robotic Angioplasty

YouTube video by Med Tech Gurus

youtube.com

[ALA Client News] Kayentis launches interactive eConsent solution to simplify and improve patient understanding of clinical trials ala.associates/product-laun... #clinicaltrials #digitalhealth #eCOA

[ALA Client News] Meteor Biotech joins consortium on seven-year brain organoids commercialization project ala.associates/partnership/... #neurology #drugdiscovery

We attended @vivatech.bsky.social 2026 in Paris last week! An incredible opportunity to connect with some of the most innovative companies shaping the future of technology and healthcare. We look forward to sharing new inspiring stories and news in the coming weeks #VivaTech2026 #deeptech

[ALA Client News] Clean Cells acquires Stem Genomics to strengthen cell therapy quality control and expand US presence ala.associates/corporate/cl... #biopharma #stemcells

[ALA Client News] Vygon Corporation receives Health Canada approval to commercialize Stiletto™ extended dwell catheters ala.associates/product-laun... #medtech #hospital @vygongroup.bsky.social

[ALA Client News] Meteor Biotech delivers talk at Spatial Omics 2026 on gaps in spatial biology mapping ala.associates/events/meteo... #SpatialOmics @vibtrainconf.bsky.social

💡TIP #4: Tailor your language to the media you are speaking to It’s important to adapt how you explain your technology to different audiences. Specialized and trade media require a different approach. They may speak your technical language, but they might not be fluent. #PR #mediatraining

[ALA Client News] Grapheal secures €2.5M from EIC Accelerator program to develop fast, field-deployable graphene sensors for ultra-trace, real-time PFAS detection ala.associates/funding/18767/ @ec.europa.eu #PFAS #EIC #deeptech

Celebrating our clients' media successes 🌟 Here are some of our May highlights: 1️⃣ Estelle Haenel, CMO of Kayentis authored an article for International Clinical Trials on the value of wearables in eCOAs.

💡TIP #3: if all spokespersons are media-trained, the delivery of your company messages will be consistent and stronger -> Interested in media training? See how ALA’s media training has helped our clients feel more confident and prepared for every interview

[ALA Client News] Cathpax roll-outs new radiation protection system Nova-X® across EMEA following very promising clinical results ala.associates/clinical/cat... #medtech #neuroradiology

[ALA Client News] BLEEDnFIRE Therapeutics launches with non-dilutive funding to advance first-in-class pan-indication therapy for rare bleeding disorders ala.associates/funding/blee... #hemophilia #innovation #hematology @inselgruppe.bsky.social @unibe.ch

Celebrating our clients' media successes 🌟 Here are some of our April highlights: 1️⃣ Exciva in Drug Discovery World. The biotech company has dosed the first patient in a clinical trial evaluating the safety and efficacy of Deraphan for the treatment of agitation in patients with #Alzheimers disease.

[ALA Client News] Exciva appoints distinguished biopharma leader Mark Altmeyer as chairman of the board ala.associates/appointment/... #alzheimers #neuropsychiatric #biopharma

[ALA Client News] Robocath completes enrollment in First-In-Human (FIH) study of next-gen robotic platform in interventional cardiology ala.associates/clinical/rob... #robotics #cardiology #clinicaltrials

[ALA Client News] Exciva doses first patient in Phase 2/3 trial of Deraphan for agitation in Alzheimer’s disease and extends Series B round ala.associates/clinical/exc... #alzheimers #clinicaltrial #seriesB

[ALA Client News] Kahimmune Therapeutics signs agreement for scientific collaboration with @gustaveroussy.fr ala.associates/partnership/... #biotech #oncology

🌟 Celebrating our clients’ media successes! March was a month of collaborations for ALA clients, here are our highlights: 1️⃣ Kayentis’ CMO Estelle Haenel spoke with BioXconomy about their new strategic partnership with Perceptive eClinical, tackling digital complexity in global clinical trials.

[ALA Client News] Kayentis and RWS join forces to improve data confidence in neuroscience clinical trials ala.associates/partnership/... #neuroscience #clinicaltrials #digitalhealth #pharma

[ALA Client News] Clean Cells and Naobios showcase complete end-to-end viral vaccines and vector solutions at BIO KOREA 2026 ala.associates/events/clean... #BIOKOREA2026

Celebrating our clients' media successes 🌟 1️⃣ @vygongroup.bsky.social in @lesechosfr.bsky.social. Acquired Stiletto®, boosting vascular access leadership. 2️⃣ PLL Therapeutics in @neurologylive.bsky.social. Positive stage I results of phase I/II trial in ALS. #PR #biotech #medtech

[ALA Client News] Perceptive eClinical and Kayentis partner to tackle increasing digital system complexity in global clinical trials ala.associates/partnership/... #clinicaltrials #digitalhealth #biotech #pharma

[ALA Client News] iPerf enrolls first patient in clinical trial of innovative dual-flow femoral arterial cannula for cardiopulmonary support ala.associates/clinical/ipe... @ap-hp.bsky.social #cardiovascular #cannula #medtech

[ALA Client News] Genoskin Showcases HypoSkin® Ex Vivo Platform at @sotoxicology.bsky.social Annual Meeting ala.associates/events/genos... #immunology #2026SOT